PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

Condition:   Asthma Interventions:   Drug: MCT;   Drug: Clazakizumab;   Drug: Broncho-Vaxom;   Drug: Imatinib Mesylate;   Drug: Cavosonstat;   Drug: Itacitinib;   Other: Placebo Sponsors:   University of North Carolina, Chapel Hill;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting

Source: ClinicalTrials.gov - October 17, 2019 Category: Research Source Type: clinical trials